|
|
The speakers
We are now assembling the speaker panel for the Barcelona Vaccine Forum 2009 and Active Immmunotherapeutics Forum 2009. Amongst the high profile speakers who have already confirmed their participation are::
|
Vaccine Forum
- Jean Stéphenne, President & General Manager, GlaxoSmithKline Biologicals
- Dr Norman W. Baylor, Director, Office of Vaccines Research & Review (OVRR), CBER, US Food & Drug Administration
- Dr Robin Robinson, Director, Biomedical Advanced Research & Development Authority (BARDA), Office of the Assistant Secretary for Preparedness & Response (ASPR), US Department of Health & Human Services
- Dr Allan P. Jarvis, Senior Vice President, Corporate Development, sanofi pasteur
- Dr Nathalie Garçon, Vice President of Research & North America R&D, GlaxoSmithKline Biologicals
- Dr René Labatut, Vice President, Global Manufacturing Technology, sanofi pasteur
- Dr Alan Shaw, President & CEO, VaxInnate Corporation
- Dr Rahul Singhvi, President & CEO, Novavax, Inc
- Dr Heather L. Davis, Site Head, Ottawa Laboratories, Vaccines Research, Pfizer Global R&D
- Dr Raf Lemmens, R&D Vaccine Program Leader, GE Healthcare Life Sciences
- Dr Steve Chatfield, Director, Centre for Emergency Preparedness & Response, Health Protection Agency
- Helen Young PhD, Director of Development, Cambridge Biostability Limited
- Hans Küpper, Partner, Global Life Science Ventures GmbH
- John M. Clerici, Partner, McKenna Long & Aldridge LLP
|
Active Immunotherapeutics Forum
- Dr Allan P. Jarvis, Senior Vice President, Corporate Development, sanofi pasteur
- Dr Nathalie Garçon, Vice President of Research & North America R&D, GlaxoSmithKline Biologicals
- Heather L. Davis, PhD, Executive Director, Pfizer Global R&D, Vaccines Research; Site Head, Ottawa Laboratories
- Dr Martin Bachmann, CSO, Cytos Biotechnology AG
- Dr Vincent Brichard, Vice President, Cancer Immunotherapeutics, GlaxoSmithKline Biologicals
- Professor Angus Dalgleish, Research Director, Onyvax Limited
- Dr Joyce Frey-Vasconcells, Executive Director, PharmaNet Consulting, PharmaNet Development Group
- Dr Jean-Yves Bonnefoy, Vice President, R&D, Transgene
- Nicole Provost, PhD, Vice President, Product Development, Dendreon Corporation
- Dr Reiner Laus, CEO, BN ImmunoTherapeutics
- Dr Habib Fakhrai, Executive Vice Chairman of the Board & CSO, NovaRX
- Dr Alex Franzusoff, Vice President, Research & Development, GlobeImmune, Inc
- Dr Alan Shaw, President & CEO, VaxInnate Corporation
- Dr Hans A. Küpper, Partner, Global Life Science Ventures
- Dr Bernd Eisele, CEO, Vakzine Projekt Management GmbH
- Frédéric Triebel, MD, PhD, Scientific & Medical Director, Immutep SA
- Isabelle Fourthin, MD, General Manager, Genopoietic
- Dr Gary Jennings, Vice President, Preclinical Development, Cytos Biotechnology
- Dr Pierpaolo Correale, Medical Oncologist, Translational Immunooncology Unit, Medical Oncology Division, Siena University School of Medicine
- Dr Deirdre McIntosh, Senior Regulatory Affairs Project Manager & Scientific Consultant, ERA Consulting (UK) Ltd
|
|
Visit this page again soon to see who else you will be able to hear from – and meet – in Barcelona this coming June.
|
©Copyright Phacilitate Limited 2008
|
Gold Sponsor
Silver Sponsor
“NMT found the pre-event networking services of invaluable use..."
Read More»
|
